Financials

News Ideas Discussions Technicals Forecast Seasonals

GSS fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to GENETIC SIGNATURES LIMITED operating, investing, and financing activities

GSS free cash flow for H1 25 is -3.22 M AUD. For 2024, GSS free cash flow was -12.1 M AUD and operating cash flow was -10.12 M AUD.

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: AUD

TTM

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—